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Studies in vitro show that globular proteins can experience the formation of native-like conforma-
tional states able to self-assemble with no need of transitions across the energy barrier for unfold-
ing, and that such processes can lead eventually to the formation of amyloid-like species.
Circumstantial evidence collected in vivo suggests that aggregation of native-like states can be a
concrete possibility for living organisms and thus more relevant than previously thought. In this
review we summarize the key observations collected on the ‘‘native-like aggregation” of the acyl-
phosphatase from Sulfolobus solfataricus, a protein that has allowed the direct monitoring and anal-
ysis of native-like aggregates for its propensity to form rapidly native-like aggregates and their slow
conversion into amyloid-like aggregates.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction aggregation starts from fully or partially unfolded conformationalMore than 40 human diseases are associated with the deposi-
tion of normally soluble and functional proteins into insoluble
aggregates having typical characteristics, such as a long and un-
branched ﬁbrillar morphology when analyzed with atomic force
microscopy [1] or electron microscopy [2], the ability to bind spe-
ciﬁc dyes [3,4] and the presence of extensive b-sheet structure [2].
These pathologies are usually referred to as protein deposition dis-
eases and the ﬁbrillar aggregates appearing at their onset are usu-
ally called amyloid ﬁbrils, at least when they accumulate in the
extracellular space [5].
One of the key issues to elucidate the pathogenesis of protein
deposition diseases is the mechanism by which such proteins con-
vert from their native state (N) into amyloid ﬁbrils. At least two
major pathways have been identiﬁed to date [5]. In some caseschemical Societies. Published by E
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d), fabrizio.chiti@uniﬁ.it (F.states. These can be either native states of intrinsically disordered
proteins or non-native states experienced by a folded protein
through an unfolding event, either partial or total. This unfolding
event leads to the exposure of aggregation prone peptide seg-
ments, which are able to form intermolecular interactions, thus
triggering aggregation [5]. More recently, a different pathway to
amyloid formation has been identiﬁed, attracting increasing atten-
tion. According to this recently described process, aggregation of
normally globular proteins can occur starting from conformational
states directly accessible from native states via thermal ﬂuctua-
tions, mutations, cis-trans proline isomerisation, or disruption of
quaternary structure, but in all cases with no need of transitions
across the major energy barrier for unfolding [6]. Such conforma-
tional states, which we will refer to as native-like states (N*), are
responsible for an increased aggregation propensity of the protein,
ultimately leading to amyloid formation [6]. They can be either
transiently formed conformations accessible through ﬂuctuations
of the native state [7] or conformational states permanently popu-
lated due to mutation or other events, i.e. states with a thermody-
namic stability higher than that of the fully folded state [8].
2. Aggregation from native-like states is a concrete possibility
in vivo
That aggregation processes in vivo for normally globular pro-
teins can involve native-like states of the precursor proteins, ratherlsevier B.V. All rights reserved.
Fig. 1. Structure of Sso AcP [20]. Regions shown to play important roles in inducing
aggregation of the protein are highlighted in dark grey [27]. These span the N-
terminal unstructured segment (residues 1–12) and the fourth b-strand (residues
83–91).
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suggested by a number of experimental observations collected on
different grounds. The ﬁrst evidence originates from the analysis
of bacterial inclusion bodies forming after the over-expression of
normally globular proteins. These are increasingly recognised to
consist of protein aggregates with morphological, structural and
tinctorial properties typical of amyloid structures, and thus useful
model systems to study amyloid formation in vivo [9–12]. The
coexistence of amyloid-like aggregates and aggregates containing
active enzymes or functional proteins within inclusion bodies
[11,13–15] suggests that in vivo proteins can effectively aggregate
from native or native-like states and form, as a ﬁrst aggregation
step, assemblies in which the folded and functional structure is lar-
gely maintained. Second, molecular chaperones can target compact
native states in addition to polypeptide chains with substantially
unfolded regions [16,17], suggesting that the cellular machinery
dedicated to prevent aggregation in vivo recognises folded states
as potentially dangerous conformational states to guard. Further-
more, it has been recently proposed that the protein quality control
machinery of Escherichia coli induces protein solubility through a
promoted degradation of aggregation-prone but functional protein
species, thus achieving a minimization of aggregation indepen-
dently of the conformational state and biological function of the
targeted proteins [18]. Third, the structural inspection of all-b pro-
teins has led to the identiﬁcation of sequence and structural adap-
tations that protect the b-strands occupying peripheral positions in
natural b-sheets (edge b-strands) [19]. Such protections have their
rationale in the fact that edge b-strands could give rise to intermo-
lecular interactions with edge b-strands of other protein molecules,
thus triggering aggregation through a propagation of the initial b-
sheets. The observation that such adaptations are effective once
the edge b-strands occupy their peripheral position in a folded b-
sheet, rather than in an unfolded conformation, is by itself a strong
indication that aggregation from fully folded states is a constant
challenge for natural proteins working in vivo and that a speciﬁc
evolutionary pressure exists to keep this process under control [19].
This evidence remains circumstantial and does not prove that
amyloid formation occurring in pathological conditions involves
the assembly of native-like folds as a ﬁrst step. However, in phys-
iological crowded environments in which normally globular pro-
teins spend most of their lifetime in a folded conformation, the
possibility that native-like states can aggregate and initiate the
process of amyloid deposition is worth our attention. Our ability
to determine whether aggregation in vivo involves directly na-
tive-like states or requires unfolding is not a purely mechanisti-
cally detail. It is rather a fundamental issue and has enormous
implications for identifying the molecular targets to design appro-
priate drugs for protein deposition diseases and for understanding,
more generally, how proteins have evolved to be soluble and how
the cellular machinery works to prevent effectively protein aggre-
gation and maintain protein homeostasis in vivo.
In our lab we have expended considerable effort in elucidating
in vitro the process of native-like aggregation of the acylphospha-
tase from Sulfolobus solfataricus (Sso AcP), a protein that is particu-
larly suitable for investigating this particular process for reasons
that will become apparent in the following sections. In this review
we shall summarize the main aspects of this process believing that
this protein paradigms many of the characteristics of native-like
aggregation.3. Sso AcP adopts a native-like state under conditions
promoting aggregation
Sso AcP is a small, a/b enzyme belonging to the acylphospha-
tase-like structural family (Fig. 1). The structure of the protein ischaracterized by a 5-stranded b-sheet facing against two a-helices
[20]. The overall Sso AcP fold displays the same babbab topology
previously described for other members of the acylphosphatase-
like family and typical of the ferrodoxin-like fold [21–25]. By con-
trast to related acylphosphatases, however, Sso AcP contains an
unstructured, 11-residue N-terminal segment [20], which plays a
major role in the aggregation of the protein (Fig. 1). The protein
is an enzyme able to hydrolyze, similarly to all other acylphospha-
tases, the phosphoanhydride bond of acylphosphates [20]. Since it
derives from a hyperthermophilic organism it also shows a high
conformational stability, amounting to 49.7 ± 2.4 kJ mol1 at pH
5.5, 25 C [20].
Sso AcP was found to aggregate in 50 mM acetate buffer, pH 5.5,
25 C, in the presence of 15–25% (v/v) 2,2,2-triﬂuoroethanol (TFE)
[26]. Before aggregation starts, Sso AcP was found to adopt, under
these conditions, a native-like state largely indistinguishable from
the fully native state. This is clearly indicated by a number of
observations. First, the analysis of the rates of folding and unfold-
ing processes under conditions promoting aggregation shows that
folding is manifold faster than unfolding (Fig. 2A) [26]. This causes
the folded state to predominate in the equilibrium between the
folded and any unfolded or partially unfolded state existing under
such conditions. Second, the protein is enzymatically active under
conditions promoting aggregation, before aggregation occurs
(Fig. 2B) [26]. This conﬁrms further that self-assembly of the pro-
tein starts from a conformational state bearing native-like features.
Third, the far- and near-UV circular dichroism (CD) spectra of a
mutant lacking the N-terminal segment and resisting aggregation
are identical, when acquired under conditions promoting aggrega-
tion, to the corresponding spectra from wild-type Sso AcP in condi-
tions in which aggregation does not occur [27]. It therefore appears
that the secondary structure content and the packing around the
aromatic residues of the Sso AcP globular unit do not undergo
detectable changes upon transfer to aggregating conditions
(Fig. 2C and D). Fourth, at the pH value of 7.5, at which wild-type
Sso AcP aggregates slowly even in the presence of TFE, the pattern
of sites cleaved by proteases under conditions of limited proteoly-
sis is similar when the protein is analyzed in the absence or in the
presence of 15% or 25% (v/v) TFE (Fig. 2E) [27]. This suggests again
an unchanged three-dimensional structure upon TFE addition.
Fig. 2. (A) Natural logarithm of folding and unfolding rate of Sso AcP as a function of TFE concentration. The plot shows folding rate (d), unfolding rate (s) and aggregation
rate (h). The gray area represents the range of TFE concentrations in which ordered aggregates able to bind ThT, ANS, and CR are formed. Readapted from Ref. [26]. (B)
Enzymatic activity of Sso AcP under different concentrations of TFE. The protein was pre-incubated for 30 min in the absence of TFE (s) and in the presence of different
concentrations of TFE (d). The gray area represents the range of TFE concentrations in which ordered aggregates able to bind ThT, ANS, and CR are formed. Readapted from
Ref. [26]. (C) Far-UV CD spectra for native wild-type (continuous line), native DN11 Sso AcP (dashed line) and DN11 Sso AcP incubated under aggregating conditions (dotted
line) for 4 h. Readapted from Ref. [27] with permission from Elsevier. (D) Near-UV CD spectra of wild-type Sso AcP in the absence of TFE (continuous line) and ofDN11 Sso AcP
in 20% TFE (dashed line). Reprinted from Ref. [27] with permission from Elsevier. (E) Location of proteolytic sites obtained for Sso AcP. The three diagrams show the results
obtained in 0%, 15%, and 25% TFE with trypsin (blue), chymotrypsin (green), subtilisin (purple), thermolysin (pink), elastase (yellow), and Glu-C (grey). The ﬁgure also shows
the location of b-strands and a-helices along the sequence according to the X-ray structure. Reprinted from Ref. [27] with permission from Elsevier.
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Sso AcP does not change substantially upon TFE addition at pH 5.5,
with only minor modiﬁcations for the chemical shifts of a few res-
idues, is the latest indication that Sso AcP maintains a folded and
largely native-like structure under conditions that promote aggre-
gation (unpublished results).
All these biophysical and biochemical analyses indicate that un-
der conditions promoting aggregation (in the presence of TFE) Sso
AcP populates a native-like state, with a secondary structure and a
packing very similar to that of the native state in conditions in
which aggregation does not occur (in the absence of TFE). However,
important differences exist between the dynamics of native Sso
AcP in the absence and presence of TFE. Under aggregating condi-tions the native-like state is characterized by a lower conforma-
tional stability than the fully native state. The values of free
energy change following unfolding (DGUF) are 22.6 ± 7.3 and
48.0 ± 1.2 kJ mol1 under conditions that do and do not promote
aggregation, respectively [27]. Hydrogen/deuterium exchange of
the backbone amides, monitored with both NMR (unpublished re-
sults) and electro-spray ionisation mass spectrometry [27], indi-
cate that most of the amides that are protected in native Sso AcP
in the absence of TFE exchange faster in the presence of the cosol-
vent and that a larger number of amides appear to have exchanged
after 1 h.
This appears to be, to date, the most signiﬁcant difference ob-
served upon transfer of native Sso AcP from non-aggregating to
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instability in the absence of large structural changes. In principle,
this causes an increased probability to populate native-like states
on the ‘‘native” side of the major energy barrier for unfolding,
but also fully or partially unfolded states on the other side of the
barrier. Thus, the observation of a native-like state with increased
dynamics and instability does not per se demonstrate that aggrega-
tion proceeds through native-like states rather than requiring
unfolding. In the next section we will see that evidence for a pro-
cess of native-like aggregation came rather from a kinetic analysis
of the aggregation process and from a structural investigation of
the early aggregates.Fig. 3. (A–C) Change of (A) ThT ﬂuorescence, (B) light scattering intensity and (C) enzym
light scattering intensity and enzymatic activity of ﬁltered solutions containing native
activity in the ﬁrst 100 s correspond to the formation of the early aggregates. The diamon
enzymatic activity assay containing both substrate and protein. The triangle in (C) in
containing Sso AcP in the presence of TFE. Readapted from [28] with permission from Else
the ﬁrst 200 s. (D and E) FTIR (D) and far-UV CD (E) spectra of native Sso AcP (continuous
from Ref. [28] with permission from Elsevier. (F) Increase of CR absorption, ThT ﬂuoresce
protoﬁbrils (PF.). Data were normalized to attribute 100% to the maximum value for ea4. Native-like Sso AcP aggregates into native-like aggregates
The dynamic, native-like state populated by Sso AcP under
aggregating conditions self-assembles through at least two
sequential phases (Fig. 3A–C) [28]. The ﬁrst phase is completed
within one minute and can be followed as a small change of the
far-UV CD spectrum, particularly as a decrease of the mean residue
ellipticity at 208 nm (Fig. 3E), and as an intense increase of light
scattering (Fig. 3B and inset therein). These assemblies, which will
be referred to as early aggregates in this review, show enzymatic
activity (Fig. 3C). The enzymatic activity can be directly attributed
to the early aggregates rather than to native-like monomers possi-atic activity during aggregation of Sso AcP. The squares in (B) and (C) indicate the
Sso AcP in the absence of TFE. The increase in light scattering and the decrease in
d in (C) indicates the residual enzymatic activity after ﬁltration of the solution of the
dicates the enzymatic activity after centrifugation and ﬁltration of the solution
vier. The inset in panel (B) represents the time course of static light scattering within
line), Sso AcP early aggregates (dashed line) and protoﬁbrils (dotted line). Reprinted
nce and ANS ﬂuorescence for native Sso AcP (N), the early aggregates (E.A.) and the
ch assay. Reprinted from Ref. [28] with permission from Elsevier.
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material by ﬁltration (Fig. 3C) [28].
The early aggregates are not able to bind Thioﬂavin T (ThT),
Congo red (CR) and 8-anilino-1-naphthalenesulfonate (ANS)
(Fig. 2F). Furthermore, they do not show a remarkable increase in
b-sheet structure, as inferred from Fourier transform infrared spec-
troscopy (FTIR) and far-UV CD (Fig. 3D and E) [28]. The far-UV CD
and FTIR spectra of the early aggregates, albeit similar to those of
native Sso AcP, highlight small changes reminiscent of the appear-
ance of further b-turn or loop structure and of the presence of
intermolecular b-sheet (Fig. 3D and E) [28]. The NMR analysis re-
cently carried out on the Sso AcP aggregates has shown a native-
like appearance of the [1H, 15N] HSQC spectrum and large D values
in the DOSY spectra, indicating that in such assemblies the individ-
ual protein molecules adopt a native-like conformation and a large
mobility, at least within the low molecular weight aggregates
(unpublished results).
Taken together, these data show that the ﬁrst aggregation phase
consists in the direct self-assembly of native-like Sso AcP mole-
cules to form early aggregates in which the individual molecules
still retain a native-like secondary and tertiary structure, with a
catalytic site that is not yet, albeit possibly distorted, unstructured
or inactivated. The early aggregates are not yet characterized by
structural and tinctorial characteristics typical of amyloid-like
structure. The comparison between the folding, unfolding and
aggregation rates at pH 5.5, 25 C and 20% (v/v) TFE indicates that
aggregation is faster than unfolding, showing that formation of the
early aggregates does not require a process of unfolding (Fig. 2A)
[26].5. Native-like aggregates convert into amyloid-like protoﬁbrils
The ﬁrst rapid aggregation phase is followed, on the time scale,
by a second slower phase, complete within 1 h [28]. Such a second
step is exponential and can be followed as a remarkable increase of
ThT ﬂuorescence (Fig. 3A), as a small decrease of light scattering
(Fig. 3B) and as a disappearance of enzymatic activity (Fig. 3C).
The aggregates formed after the second phase appear as spheres
or short and thin ﬁbrils, having a diameter of 3–5 nm, as inferred
from transmission electron microscopy [26,28]. By contrast to
early aggregates, these species are able to bind ThT, CR and ANS
(Fig. 3F), are not enzymatically active (Fig. 3C) and possess exten-
sive b-sheet structure as deduced from far-UV CD and FTIR spec-
troscopy (Fig. 3D and E) [26,28]. These morphological, structural
and tinctorial properties have been observed for other peptide
and protein systems and deﬁne species often referred to as amy-
loid-like protoﬁbrils [29–32]. The binding to ANS suggests that
hydrophobic clusters are exposed on the surface of these structures
and may explain their tendency to assemble further and form lar-
ger clusters of aggregates visible in transmission electron micros-
copy images and detectable by DLS [26,28].
The early aggregates diluted into conditions in which aggrega-
tion does not take place are inevitably committed to convert into
amyloid-like protoﬁbrils, whereas the native protein does not
aggregate when incubated in the same conditions [28]. These ki-
netic tests have indicated that these protoﬁbrillar species form di-
rectly from early aggregates with no need of their disassembly and
that the latter species are thus on pathway to amyloid formation
[28]. Furthermore, we showed that, while the rate constant of
the ﬁrst aggregation phase depends on protein concentration, the
rate constant for the second aggregation phase is largely indepen-
dent of the amount of protein in solution [28,33]. These observa-
tions suggest that, while formation of early aggregates is an
intermolecular process which requires interaction of monomers,
protoﬁbril formation involves a structural reorganisation withinpreformed early oligomers, from a native-like fold into an amy-
loid-like one [33].
The existence of such phase is not surprising. It was found that
when the native state is in a prevalently b-sheet structured confor-
mation the resulting aggregates present cross-b structure perpen-
dicular to the ﬁbril axis and do not require further rearrangement
[34–36]. However, when the native state consists of a conforma-
tion containing not only b-sheet structure, a reorganization of
the structure from the initial native-like aggregates is required to
reach the amyloid-like cross-b structure, which is at a minimum
of the free energy proﬁle [6].6. The intermolecular interaction between the N-terminal
segment and the globular unit promotes native-like
aggregation
In order to get insight into the process of Sso AcP self-assembly
at a molecular level, the regions of the sequence that promote the
formation of the early aggregates were investigated. It was ﬁrst
found that a mutant of Sso AcP lacking the ﬁrst 11 unstructured
residues and thus consisting only of the globular unit of the mole-
cule (DN11 Sso AcP) is not able to aggregate into either the early or
the later aggregates under conditions promoting aggregation of the
wild-type protein, even though it maintains the same native-like
fold [27]. However, peptides corresponding to the initial 11
unstructured residues (N11) or 14 residues (N14) of Sso AcP also
do not aggregate in the same conditions. Solubility assays, far-UV
CD and DLS show that the peptides are soluble, monomeric and
unstructured [27]. Furthermore, DN11 Sso AcP does not aggregate
even when it is incubated in the presence of 25 molar excesses of
the N11 peptide (Fig. 4A) or in the presence of 4 molar excesses of
the wild-type protein [33]. Taken together, these experiments
show that neither the unstructured N-terminal segment nor the
globular unit of Sso AcP can aggregate when separated from each
other and that the two parts of the protein need to be covalently
bound to trigger the process [33].
Limited proteolysis experiments performed with 6 different
proteases showed that, in both the absence and presence of TFE,
the regions of monomeric Sso AcP exposed to the solvent and/or
ﬂexible span the N-terminal segment, the b-hairpin between b-
strand 2 and 3 and the b-strand 4 (Fig. 2E) [27]. It was hypothe-
sised that either the second or the third region could have a degree
of solvent-exposure and ﬂexibility sufﬁcient to participate to the
formation of intermolecular interactions with the unstructured
N-terminus of another Sso AcP molecule. Based on these results a
number of mutants were produced with amino acid substitutions
contained in the two suspected regions and others. A negative cor-
relation was then found between the decrease in conformational
stability of the native state following mutation and the rate con-
stant for the formation of early aggregates of the corresponding
protein variant, conﬁrming the importance of ﬂexibility within
the native-like state of Sso AcP in promoting aggregation
(Fig. 4B) [27]. However, only mutants of residues in the b-strand
4 and in the N-terminal segment signiﬁcantly deviate from this
correlation, suggesting that these regions play an additional, differ-
ent role (Fig. 4B) [27].
The structural inspection of Sso AcP and of the second acylphos-
phatase from Drosophila melanogaster (AcPDro2), which also aggre-
gates directly from a native-like state [37], shows that such
proteins differ from human muscle acylphosphatase (mAcP) and
the N-terminal domain from E. coli HypF (HypF-N), which by con-
trast aggregate via unfolding [38,39], for two structural features: (i)
the higher number of unstructured regions and loops and (ii) the
lower number of protections at the edge b-strands [40]. Accord-
ingly, both deletion of the unstructured N-terminal segment and
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inhibit formation of the early aggregates (Fig. 4C), establishing a
role of these two sequence regions in the process [27,40]. Recent
NMR experiments have shown that the regions of the sequence
with the highest density of changes of 1H and 15N chemical shiftsFig. 4. (A) Time course of ThT ﬂuorescence during incubation of DN11 Sso AcP in aggreg
symbols). Data are shown for 2-fold (j), 5-fold (d), 10-fold (N) and 25-fold (.) molar ex
and in the absence (F0) of protein. The kinetic trace for wild-type Sso AcP in the same con
is not able to restore aggregation of DN11 Sso AcP. Readapted from Ref. [33] with permiss
the change of conformational stability of Sso AcP upon mutation, (DDGUF). Mutations
from the correlation. Reprinted from Ref. [27] with permission from Elsevier. (C) Format
(black), V84P (blue), V84D (green) and Y86E (red). The plot shows that the introduction
Reprinted from Ref. [40] with permission of ACS Publications. (D) First phase of Sso AcP a
excess of N11 peptide (red d) and of a control peptide having the same amino-acid conte
N11 peptide is able to slow down aggregation of Sso AcP while the control peptide is not.
the aggregation of Sso AcP (readapted from [33]). Three phases are depicted: (i) convers
aggregates; (iii) conversion of early aggregates into amyloid-like protoﬁbrils.upon conversion of the native state into the early aggregates in-
volve the N-terminus and the region encompassing b-strand-4, b-
strand-5 and the loop between them. They also showed that other
regions undergo other changes, although limited to a small number
of residues within them. This conﬁrms the involvement of the N-ation promoting conditions in the presence of different molar excesses of N11 (red
cesses. The signal is shown as a ratio between ThT ﬂuorescence in the presence (F)
ditions with no peptides (blackd) is shown for comparison. The data show that N11
ion from Elsevier. (B) Dependence of the rate of formation of early aggregates (k) on
of residues belonging to the fourth b-strand (residues 83–91) signiﬁcantly deviate
ion of early aggregates in a set of Sso AcP variants. Traces are shown for wild-type
of protective mutations on the fourth b-strands abolishes native-like aggregation.
ggregation, monitored using static light scattering, in the presence of a 4-fold molar
nt as N11 but presenting different primary sequence (blue d). The trace shows that
Reprinted from Ref. [33] with permission from Elsevier. (E) Proposed mechanism for
ion of the native state (N) into native-like state (N*); (ii) conversion of N* into early
2636 F. Bemporad, F. Chiti / FEBS Letters 583 (2009) 2630–2638terminal segment and of the region comprising b-strand 4, and
possibly the following segments, in the formation of the early
aggregates.
If these experiments provided important information on the re-
gions of the Sso AcP sequence promoting the formation of the early
aggregates they did not, however, allow the formulation of a model
able to account for the mechanism of the process at a molecular le-
vel. In follow-up studies it was found that a mutant in which the
unfolded segment was moved from the N-terminus to the C-termi-
nus exhibits the same aggregation properties as the wild-type pro-
tein [33]. The N- and C-terminus of Sso AcP are distant from each
other, suggesting that speciﬁc intra-molecular interactions be-
tween the segment and the globular unit within the native-like
monomeric state are unlikely to be necessary prerequisites for
the process. In fact, such interactions would necessarily be affected
by moving the unstructured segment to the distant C-terminus.
Furthermore, aggregation of wild-type Sso AcP was found to be
slower in the presence of the N11 peptide, whereas it was not af-
fected by a peptide bearing the same amino-acid content as the
N11 peptide but a scrambled, primary sequence (Fig. 4D) [33]. This
suggests that the N11 peptide interacts with the wild-type protein
inhibiting its aggregation. It also suggests that the interaction be-
tween the unstructured N-terminal segment and the globular unit
of the molecule is intermolecular, as in the case of intra-molecular
interactions the N11 peptide should speed up the process or pro-
duce no effect. The ability of the N-terminal segment to induce
aggregation of the full length protein does not appear to be due
to its overall physicochemical properties dictated by the amino
acid composition, but rather to its primary sequence. Correspond-
ingly, the interaction between this portion and the globular unit of
the Sso AcP molecule is seemingly a speciﬁc one.
In contrast to the ﬁrst phase of aggregation, the conversion of
the early aggregates into the amyloid-like protoﬁbrils seems to
be a cooperative process involving the whole molecule. A signiﬁ-
cant correlation was found between the change in conformational
stability of the native state following mutation and the rate con-
stant for the conversion of the early aggregates into the later pro-
toﬁbrils, with no mutants deviating signiﬁcantly from this trend
[27]. This result indicated that ﬂexibility within the early aggre-
gates is an important factor promoting their conversion and that
such conversion is a cooperative process involving the whole Sso
AcP molecule [27].
These experiments led us to the formulation of a model for the
aggregation of Sso AcP (Fig. 4E) [33]. In this model the major event
in the self-assembly of native-like Sso AcP into native-like aggre-
gates (ﬁrst phase) is the establishment of a speciﬁc intermolecular
interaction between the N-terminal segment of one Sso AcP mole-
cule and the globular unit of another one, probably at the level of
the b-strand 4. A structural ﬂexibility involving the whole molecule
is also a necessary prerequisite for the process to occur. This model
is similar to a model proposed for the aggregation of the prion
Ure2p, in which an unstructured segment interacts with the glob-
ular part of another molecule [41] and to the mechanism proposed
for the assembly of serpins, in which a loop interacts with the b-
sheet of another molecule, triggering self-assembly [42]. In the
case of human transthyretin (TTR) it was shown that aggregation
requires the dissociation of the native tetramer and the formation
of a monomer in which two edge b-strands are unfolded. This leads
to the exposure of other regions which trigger self-assembly [6,43].
It is possible that also in the case of Sso AcP the edge b-strand 4
does not directly establishes interactions with the N-terminal seg-
ment but participates to the structural ﬂuctuations from the native
state to form native-like states. Further investigation will be re-
quired to shed light on this issue. The conversion of the early
aggregates into the amyloid-like protoﬁbrils involves the whole
Sso AcP molecule and is a cooperative process.7. Stabilisation of the native state is an effective therapeutic
strategy to inhibit native-like aggregation
The addition of ligands binding to the native state of Sso AcP,
such as the phosphate ion, was found to slow down considerably
both the conversion of the native-like state into the early aggre-
gates as well as the subsequent conversion of these oligomers into
the later protoﬁbrils [44]. The rationale of this ﬁnding lies in the
ability of this ligand to generate, through speciﬁc binding, a sort
of crystallisation of the native state inhibiting both kinetically
and thermodynamically not just the unfolding process, but also
the structural ﬂuctuations that are necessary to reach the native-
like state and initiate aggregation. The conversion of the early na-
tive-like aggregates into the amyloid-like protoﬁbrils is also inhib-
ited by ligand binding for similar reasons. This result raises
optimism in the utilisation of therapeutic strategies aimed at
inhibiting pathways of aggregation such as those observed here
for Sso AcP. Indeed, stabilisation of the native state through speciﬁc
ligand binding, or via any other strategy, is anticipated to be an
effective means to inhibit both native-like and unfolding-based
aggregation processes and a promising avenue in the search of
an effective cure of protein deposition diseases associated with ini-
tially globular proteins. Important results have been obtained with
this strategy in the case of TTR aggregation [45]. However, the de-
sign of therapeutic strategies aimed at interfering directly with the
formation of intermolecular interactions requires a knowledge of
both the aggregation pathway followed by a protein and the
molecular level at which this occurs.8. Conclusions and future perspectives
The aggregation process of Sso AcP recapitulates many of the
fundamental features of the aggregation pathway starting from na-
tive-like states. The formation of the native-like state does not in-
volve any global unfolding event but involves thermal ﬂuctuations
from the fully native state or other events that are however distinct
from unfolding processes across the major energy barrier for
unfolding. Aggregation of Sso AcP leads to the formation of assem-
blies in which the individual molecules maintain initially a struc-
ture similar to the initial aggregation prone state in its
monomeric form, which in this case presents a native-like fold.
Since the Sso AcP native fold does not contain only b-sheet struc-
ture, a second aggregation phase is necessary in which the amy-
loid-like fold is reached. Processes of native-like aggregation in
which the proteins aggregate from native-like states and maintain
either transiently or permanently a native-like structure in
the aggregates are reported for other systems [6,34–36,41–
43,46–48].
Mechanisms of native-like aggregation such as those described
here for Sso AcP and described elsewhere for other systems have
been observed and studied in vitro, in an environment and context
far from that existing in vivo. Nevertheless, the observation that
native-like aggregates can also form in vivo, for example in bacte-
rial inclusion bodies which are demonstrated to be good model
systems to study the formation and structure of amyloid ﬁbrils
in living organisms [9,10,12–14], provides a strong indication that
folded proteins have a signiﬁcant propensity to aggregate. The
ﬁnding that proteins have evolved structural and sequence adapta-
tions to counteract aggregation of their folded states, such as that
described to protect their edge b-strands from aggregation only
when they are structured in native b-sheets [19], is perhaps one
of the strongest indications that native-like aggregation is a chal-
lenge for any living system against which an evolutionary pressure
has been exerted. Along the same lines, the increasing evidence
that the cellular machinery dedicated to the maintenance of pro-
F. Bemporad, F. Chiti / FEBS Letters 583 (2009) 2630–2638 2637tein homeostasis is effective in inhibiting aggregation of folded
states, in addition to counteract aggregation of proteins in their
fully or partially unfolded states, suggests that native-like aggrega-
tion is per se a challenge in the cell [16–18].
Further investigation is needed to shed light on the structural
and dynamical properties of the native-like amyloidogenic state
and on the molecular mechanism by which this converts into na-
tive-like aggregates down to the amyloid-like protoﬁbrils and ﬁ-
brils. Novel experimental design and technology are also
required to detect and characterise processes of this type in vivo,
with an aim of understanding maintenance of protein homeostasis
in biology and occurrence of protein aggregation in pathology. The
elucidation of protein aggregation at the molecular level will have
implications in the search for therapeutic strategies speciﬁc for the
identiﬁed pathway. It will also have important implications in bio-
technology as our anticipated ability to produce large amounts of
functional proteins in the form of inclusion bodies can have impor-
tant exploitable implications.References
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